4//SEC Filing
Finn John 4
Accession 0001181431-13-017383
CIK 0001356857other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 2:52 PM ET
Size
5.5 KB
Accession
0001181431-13-017383
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-03-15$7.10/sh−1,500$10,650→ 190,360 total(indirect: By Trust)
Holdings
- 1,782
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012.
- [F2]Includes 343 shares acquired May 18, 2012 and 465 shares acquired November 20, 2012 pursuant to the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeother
Related Parties
1- filerCIK 0001479788
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 2:52 PM ET
- Size
- 5.5 KB